Global challenges to public health care systems during the COVID-19 pandemic: a review of pandemic measures and problems

R Filip, R Gheorghita Puscaselu… - Journal of personalized …, 2022 - mdpi.com
Beginning in December 2019, the world faced a critical new public health stressor with the
emergence of SARS-CoV-2. Its spread was extraordinarily rapid, and in a matter of weeks …

COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention

A Sharma, I Ahmad Farouk, SK Lal - Viruses, 2021 - mdpi.com
Three major outbreaks of the coronavirus, a zoonotic virus known to cause respiratory
disease, have been reported since 2002, including SARS-CoV, MERS-CoV and the most …

[HTML][HTML] Post COVID-19 pulmonary fibrosis; a meta-analysis study

BJH Amin, FH Kakamad, GS Ahmed, SF Ahmed… - Annals of Medicine and …, 2022 - Elsevier
Introduction; Pulmonary fibrosis is a frequently reported COVID-19 sequela in which the
exact prevalence and risk factors are yet to be established. This meta-analysis aims to …

Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan

T El-Elimat, MM AbuAlSamen, BA Almomani… - Plos one, 2021 - journals.plos.org
Vaccines are effective interventions that can reduce the high burden of diseases globally.
However, public vaccine hesitancy is a pressing problem for public health authorities. With …

[HTML][HTML] Considerations for diagnostic COVID-19 tests

O Vandenberg, D Martiny, O Rochas… - Nature Reviews …, 2021 - nature.com
During the early phase of the coronavirus disease 2019 (COVID-19) pandemic, design,
development, validation, verification and implementation of diagnostic tests were actively …

Attitudes toward a potential SARS-CoV-2 vaccine: a survey of US adults

KA Fisher, SJ Bloomstone, J Walder… - Annals of internal …, 2020 - acpjournals.org
Background: Coronavirus disease 2019 (COVID-19) has rapidly instigated a global
pandemic. Vaccine development is proceeding at an unprecedented pace. Once available …

Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study

G Grasselli, T Tonetti, A Protti, T Langer… - The lancet Respiratory …, 2020 - thelancet.com
Background Patients with COVID-19 can develop acute respiratory distress syndrome
(ARDS), which is associated with high mortality. The aim of this study was to examine the …

A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples

VL Dao Thi, K Herbst, K Boerner, M Meurer… - Science translational …, 2020 - science.org
The coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 (severe
acute respiratory syndrome coronavirus 2) coronavirus is a major public health challenge …

Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)

AR Bourgonje, AE Abdulle, W Timens… - The Journal of …, 2020 - Wiley Online Library
Abstract Angiotensin‐converting enzyme 2 (ACE2) has been established as the functional
host receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus …

Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series

SF Lax, K Skok, P Zechner, HH Kessler… - Annals of internal …, 2020 - acpjournals.org
Background: Coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become pandemic, with …